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ABSTRACT 
Background: 
Holoprosencephaly (HPE) is the most common forebrain defect in humans. It results from 
incomplete midline cleavage of the prosencephalon.  
Methods:  
We report a large European series of 645 HPE probands (and 699 relatives), consisting of 
51% foetuses and 49% liveborn children.  
Results:  
Mutations in the four main genes involved in HPE (SHH, ZIC2, SIX3, TGIF) were identified in 
25% of cases. The SHH, SIX3 and TGIF mutations were inherited in more than 70% of these 
cases, whereas 70% of the mutations in ZIC2 occurred de novo. Moreover, rearrangements 
were detected in 22% of the 260 patients screened by array-CGH. Fifteen probands had two 
mutations providing additional support for the "multiple-hit process" in HPE. There was a 
positive correlation between the severity of the brain malformation and facial features for 
SHH, SIX3 and TGIF, but no such correlation was found for ZIC2 mutations. The most 
severe HPE types were associated with SIX3 and ZIC2 mutations, whereas microforms were 
associated with SHH mutations. We focused on the associated brain malformations, 
including neuronal migration defects, which predominated in individuals with ZIC2 mutations, 
and neural tube defects, which were frequently associated with ZIC2 (rachischisis) and TGIF 
mutations. Extra-craniofacial features were observed in 27% of the individuals in this series 
(up to 40% of those with ZIC2 mutations) and a significant correlation was found between 
renal/urinary defects and mutations of SHH and ZIC2.  
Conclusions: 
We propose an algorithm based on these new phenotype-genotype correlations, to facilitate 
molecular analysis and genetic counselling for HPE. 
 
 
 
INTRODUCTION 
 
Holoprosencephaly (HPE; MIM#236100) is the most common brain malformation in humans. 
It results from incomplete midline division of the prosencephalon between days 18 and 28 of 
gestation.[1],[2] The estimated prevalence of HPE in liveborn children is less than 1/10,000, 
but the incidence may be as high as 1/250 in first-trimester conceptuses.[3, 4] HPE is usually 
associated with facial abnormalities, such as cyclopia, proboscis, or cleft lip/palate in cases 
of severe HPE. It has been said that “the face predicts the brain” but this rule is not 
applicable in all cases.[5, 6] Three classical anatomical classes have been described, in 
increasing order of severity: lobar, semi-lobar and alobar HPE. The full spectrum of HPE also 
includes middle interhemispheric variants (MIH) or syntelencephaly, septopreoptic HPE and 
microforms characterised by midline defects (e.g. single maxillary median incisor (SMMI) or 
hypotelorism) without the brain malformations typical of HPE.[7, 8, 9, 10] 
 
Not only is HPE phenotypically highly variable, its aetiology has also been shown to be very 
heterogeneous.[11, 12, 13] Indeed, HPE may be caused by chromosome abnormalities, 
such as trisomy 13, 18 and triploidy in particular, or may be one of the components of a 
multiple malformation syndrome, such as Smith-Lemli-Opitz or CHARGE syndrome. HPE 
may also result from exposure to maternal diabetes or hypocholesterolaemia during 
gestation.[14, 15] Four major genes responsible for HPE have been characterised — SHH, 
ZIC2, SIX3 and TGIF — and another nine seem to play a lesser role in the occurrence of 
HPE.[13] The “multiple-hit hypothesis” is now the most widely accepted model of HPE. 
According to this hypothesis, combinations of mutations in major and/or minor HPE genes 
lead to the occurrence of HPE and may account for variability in terms of severity.[16] 
Genetic counselling thus remains very complex for families affected by HPE.[17] There are 
clearly many interactions between the various signalling pathways involved in forebrain 
development that remain to be elucidated.  
 
It is therefore difficult to establish phenotype-genotype correlations for this disease, due to 
the large number of interacting factors. Studies of large series are therefore required. We 
and others have reported specific findings, including, in particular, the description of 
particular microforms often associated with SHH, the predominance of severe forms in 
subjects with SIX3 mutations and a ZIC2-specific phenotype with minor facial features.[6, 9, 
18, 19, 20, 21] 
 
We report here clinical and molecular data for the largest ever European series, including 
645 probands and their relatives and a high proportion of foetuses; only one larger series has 
been described, based solely on children with HPE (NIH, Muenke’s team).[21] We aimed to 
identify new phenotype-genotype correlations in an updated large series of probands with at 
least one mutation in an HPE-related gene and/or at least one rearrangement identified on 
array-CGH analysis. Our statistical analyses confirm previous reports and focus, for the first 
time, on additional features, such as associated brain malformations, neural tube defects and 
extra-craniofacial defects. These new phenotype-genotype correlations should help to guide 
molecular analysis strategies and, thus, genetic counselling.  
 
 
PATIENTS AND METHODS 
 
In 1996, a European network for HPE was set up in Rennes, France.[1, 9, 18, 22] Clinical 
data for about 1500 patients, including 645 HPE probands and 699 relatives, were analysed 
and DNA was prospectively collected. All the data were input into a specific secure online 
database.  
This study was approved by the institutional review board. All samples and clinical data were 
collected after informed consent had been obtained. 
 
Molecular analyses 
The four major HPE-associated genes (SHH, ZIC2, SIX3 and TGIF) were routinely analysed 
by D-HPLC and/or direct sequencing in probands. The mode of inheritance was determined 
in cases in which samples from the parents were available. We analysed the GLI2 gene in 
208 HPE patients selected on the basis of a pituitary gland defect.[23, 24, 25]  
 
We also searched for microcytogenetic rearrangements by multiplex ligation probe 
amplification (MLPA) (MRC-Holland) on the four genes. Array-CGH was performed with the 
Agilent Human Genome Microarray 44A and 244A kits (Agilent Technologies, Santa Clara, 
CA), for 260 patients.[26] 
 
Clinical data 
We collected data relating to facial morphology and associated features. This study focused 
on HPE patients without known chromosomal abnormalities that could be picked up by 
standard cytogenetic analysis and without identified syndromes. 
 
We defined four categories of facial abnormality, in descending order of medical severity: (1) 
very severe phenotypes, such as cyclopia, ethmocephaly (proboscis), cebocephaly; (2) 
premaxillary agenesis, cleft lip or palate and less severe eye abnormalities (coloboma, retinal 
dysplasia); (3) mild midface malformations, such as pyriform sinus stenosis and choanal 
stenosis; (4) the mildest abnormalities, such as hypotelorism, solitary median maxillary 
incisor (SMMI), other mild non-specific defects and normal faces.  
 
Associated brain malformations not included in the typical spectrum of HPE were also 
considered. These malformations included, in particular, posterior fossa abnormalities, such 
as rhombencephalosynapsis (RES), cerebellar hypoplasia and agenesis, but also pituitary 
defects and gyral and neuronal abnormalities. Neural tube defects, such as 
myelomeningocele, rachischisis and spina bifida, were considered independently of the 
associated brain malformations.  
 Extracraniofacial defects were essentially classified into six groups: (i) heart defects; (ii) 
visceral malformations (abnormal lung lobulation, lung hypoplasia, thymus hypoplasia, 
adrenal hypoplasia, adrenal cytomegaly, common mesentery, single umbilical artery, 
diaphragmatic hernia, exomphalos, inguinal hernia, oesophageal atresia, intestinal stenosis); 
(iii) genital malformations (micropenis, hypospadias, external and internal genital organs); (iv) 
renal/urinary abnormalities (ureteral dilatation, renal hypoplasia); (v) skeletal abnormalities 
(sacral agenesis and costovertebral abnormalities); (vi) abnormalities of the extremities (club 
hand or foot, postaxial polydactyly, brachydactyly, clinodactyly or simian crease).  
 
 
Statistical analysis 
The percentages in this report were calculated for the patients with documented data, as 
exhaustive clinical data were not available for all cases. 
 
Variables are expressed as numbers and percentages. Comparisons were based on 
Pearson’s chi² test and Fisher’s exact tests, as appropriate. Correlations between ordinal 
variables were analysed by calculating Spearman’s rank correlation coefficient and 
Goodman and Kruskal’s gamma. We used a type I error of 0.05, by convention, and all 
analyses were studied carried out with R software version 2.12.2 (2011-02-25).[27] 
 
RESULTS 
The main data, including HPE type, facial abnormality category, associated brain 
malformations, neural tube defects and extracraniofacial malformations, are shown in table 1. 
Table 1: Clinical data for the entire series, probands with alterations to the four main 
HPE-associated genes (SHH, ZIC2, SIX3, TGIF) and with abnormal array-CGH data. 
Percentages are expressed according to the data recorded (500 probands for HPE type and 
face defect category) and correspond to the ratio of each feature reported in the probands of 
the group concerned, with the exception of detailed extracraniofacial defects, which are 
expressed as a proportion of the total of extracraniofacial defects in each group. # Array-CGH 
was performed on 260 probands. In addition to the HPE types mentioned in the table, septo-
optic dysplasia and atelencephaly were reported in 1.4% and in 0.6%, respectively, of the 
cases in this series. Statistical analyses were carried out by comparing the SHH, ZIC2, SIX3, 
TGIF subgroups and probands without modifications to any of the four genes. * Significant 
differences were found for of the distribution of HPE type (p=3.8 x 1010), face defect category 
(p=9 x 1010) and renal/urinary defects (p=0.03) in Fisher’s exact tests.  
 
The series 
The series contained 645 probands, including 51% foetuses, and 699 relatives. The sex ratio 
of 1.2 (F:M) was consistent with a slight female predominance.  
 
Systematic molecular analyses showed point mutations or deletions in the four major genes 
involved in HPE (SHH, ZIC2, SIX3 and TGIF) in 25.4% of the subjects (164 probands; Figs. 
1 and 2)[6, 18, 21, 28, 29, 30] More foetuses than children were found to carry an HPE-
associated gene deletion (68% vs 32%). Previous array-CGH analysis showed 
rearrangement rates as high as 25% in an initial study of 120 patients.[26] We describe here 
an additional 140 undergoing screening, with rearrangements identified in 22% (n=56) of the 
total of 260 probands. (Table 1) 
 
HPE type Face defect category Extracraniofacial defects 
 Probands 
alobar semilobar lobar MIH microform Cat I Cat II 
Cat 
III 
Cat 
IV 
Associated 
brain 
malformations 
Neural 
tube 
defect % of 
probands Heart Visceral Genital Renal/urinary Skeletal Extremities 
Total 
cohort 645 
25% 
+ 1% 
atelencephaly 
28% 19% 2% 25% 27% 19% 14% 40% 13% 4% 27% 19% 23% 11% 11% 8% 27% 
SHH 67 (10.4%) 28%* 34%* 4%* 0%* 34%* 38%* 22%* 26%* 14%* 9% 5% 24% 8% 24% 8% 28%* 16% 16% 
ZIC2 53 (8.2%) 30%* 45%* 15%* 8%* 2%* 8%* 8%* 3%* 81%* 
21% 
(15% neuronal 
migration) 
9% 40% 14% 20% 17% 14%* 9% 26% 
SIX3 33 (5.1%) 
52%* 
+ 7% 
atelencephaly 
15%* 11%* 0%* 15%* 45%* 24%* 10%* 21%* 7% 7% 24% 0% 22% 11% 0%* 22% 45% 
TGIF 11 (1,7%) 43%* 14%* 29%* 0%* 14%* 55%* 27%* 0%* 18%* 9% 9% 27% 25% 50% 12% 0%* 0% 13% 
CGH 56
# 
(22%) 19% 37% 17% 0% 27% 8% 38% 8% 46% 11% 4% 26% 19% 22% 17% 11% 11% 20% 
Most severe cases of HPE were assigned to facial defect category 1 or 2, whereas most of 
microforms were classified as category 3 or 4 (Fig. 3). As expected, category 4 included all 
cases of MIH and, surprisingly, a relatively high proportion of the cases of alobar or 
semilobar HPE. RES, the equivalent of HPE in the cerebellum, was described in six HPE 
cases and schizencephaly was reported as potentially associated in only three cases.[31] 
Extracraniofacial features were observed in 70 cases, including 13 cases of multiple 
congenital malformations mostly concerning abnormalities of the extremities, such as club 
hand or foot, simian crease, postaxial polydactyly (5 cases) and visceral malformations, 
frequently with lung defects. Furthermore, three cases of situs inversus were observed. 
 
An HPE spectrum disorder was reported in 79 of the 699 relatives (29% in parents and 71% 
in other relatives). All affected parents were diagnosed with brain microforms, which 
accounted for 44% of the abnormalities in these 79 relatives. More severe forms were 
reported in other relatives, such as siblings or cousins: 26% alobar HPE, 13% semi-lobar 
HPE and 7% lobar HPE. Facial abnormalities were correlated with HPE severity: 26% 
category 1, 13% category 2, 10% category 3 and 51% category 4. Associated brain 
malformations were observed in 6% of the affected relatives and neural tube defects were 
found in 8%. Extracraniofacial malformations were reported in 16% of relatives, including 
only two cases of multiple congenital malformations.  
 
SHH 
 
SHH mutations were found in 67 probands (10.4%) and in 47 relatives from 59 different 
families, confirming that SHH was the gene most frequently mutated in HPE. An HPE 
spectrum disorder was described in 13 relatives: 1 lobar case and 11 microforms (1 non 
documented). We found that 23% of the parents with SHH mutations presented a microform. 
Brain MRI revealed the presence of midline defects, such as an abnormal corpus callosum in 
the mother of one proband.  
 The sex ratio (F:M) was more balanced in SHH probands than in the series as a whole (0.9). 
The four categories of facial features were evenly distributed and microforms were, above all, 
associated with pyriform sinus and choanal stenosis (74% category 3). The proportion of 
coloboma cases was relatively high (15% of the series as a whole). Associated brain 
malformations mostly concerned posterior fossa abnormalities (7%). Extracraniofacial 
abnormalities included five cases of multiple congenital malformations, mostly visceral and 
renal/urinary defects. Sacral agenesis was also observed (associated in one case with 
costovertebral abnormalities) in several probands with large 7q36 deletions, including the 
HLXB9 gene in particular (Currarino syndrome, MIM#176450).  
 
ZIC2 
 
ZIC2 mutations were identified in 53 probands (8.2%) and 14 relatives. Microforms were 
reported in 36% of the parents with ZIC2 mutations (4/11). The sex ratio (F:M) of 1.8 was 
consistent with a marked predominance of female subjects. HPE tended to be alobar or 
semilobar (72%). Furthermore, only two HPE-related gene mutations were found in the 11 
MIH cases in the total series, and both were ZIC2 mutations.  
 
The probands of the ZIC2 group tended to have a combination of severe HPE with few facial 
features. Other specific findings were obtained for associated brain malformations, neural 
tube defects and extracraniofacial malformations. The neuronal migration abnormalities 
(15%) detected were lissencephaly, polymicrogyria or pachygyria in four cases and 
heterotopia in white matter and/or in the cerebellum in another four cases. One foetus with 
lobar HPE had heterotopia and gyration abnormalities among other multiple congenital 
anomalies (rachischisis, cleft palate, visceral and extremity abnormalities). Neural tube 
defects were reported in five cases, including two cases of rachischisis: one combined with 
pseudoanencephaly and the other with anencephaly with facial clefting in a monozygous twin 
previously reported by Lazaro et al.[9] Both the cases of rachischisis in the overall series 
were found to have a ZIC2 mutation. A high proportion of extracraniofacial abnormalities, 
mostly visceral abnormalities and abnormalities of the extremities, was associated with ZIC2 
mutations, including eight cases of multiple congenital malformations.  
 
SIX3 
 
SIX3 mutations were identified in 33 probands (5.1%) and 21 relatives. Microforms were 
found in three of the 17 parents. The sex ratio was in favour of a higher proportion of 
females. Very severe HPE, such as alobar HPE and atelencephaly, was described in 57% of 
cases. In one family, a missense mutation was found in a mother and her three foetuses with 
alobar HPE or atelencephaly.[32, 33]  
 
Probands with SIX3 mutations mostly had severe facial features (category 1 or 2). Severe 
ophthalmological defects were often reported with SIX3 mutations, as shown by a high 
percentage of category 1 abnormalities, and coloboma was found in two category 2 cases. 
Associated brain malformations were mentioned in only 6% of the probands with SIX3 
mutations, including one case of gyrus abnormality associated with heterotopia. Finally, only 
one case of multiple congenital malformations was reported, with no heart defects among the 
extracraniofacial features. 
 
 
TGIF 
 
TGIF mutation was found in only 11 probands (1.7%) and eight relatives, including five 
parents with no reported HPE spectrum disorder. The sex ratio (1.3) was similar to that for 
the series as a whole. HPE tended to be of the alobar type, and facial defects were mostly 
severe: 82% of probands were classified as category 1 or 2. Associated brain malformation 
was reported in only one case of ectopic posterior pituitary gland. The extracraniofacial 
abnormalities were not specific (one case of multiple congenital malformations).  
 
GLI2 
Evidence for a minor role of GLI2 was provided by the very low rate of mutations in this gene 
in HPE spectrum disorders. Indeed, GLI2 mutation was found in only three probands (1.4% 
in selected patients) and three relatives. Two of these missense mutations may be involved 
in the disorder but the pathogenicity of the third mutation could not been established with 
certainty. Samples from the parents were available for one patient, and analysis of these 
samples showed the mutation to be inherited. The brain malformations observed were lobar, 
semi-lobar and alobar HPE with facial abnormalities of category 2 or 4 (one undocumented 
case).  
 
Interestingly, one foetus presented the combination of a GLI2 missense mutation, inherited 
from an asymptomatic mother, with a de novo 13q deletion including the ZIC2 gene. The 
proband had alobar HPE with complex heart malformations, bilobulated lung, gallbladder 
agenesis, hypospadias, no thumb or first metacarpal and ungual hypoplasia.  
 
Microrearrangements  
Array-CGH analysis identified rearrangements in 22% (56 cases) of the 260 probands. 
These rearrangements had arisen de novo in 14% and were inherited in 8%. They consisted 
of 45 isolated microdeletions (80%), including one ring chromosome and 19 
microduplications (20%), with double rearrangements in eight cases. The rearrangement 
included one of the main HPE genes (SHH, ZIC2 or TGIF) in eight probands. Recurrent 
rearrangements, involving MACROD2 (20p) in seven cases and PATCHD3 (10p) in six 
cases, were found to occur at a higher rate than in the general population.  
 
The 56 probands with rearrangements included 59% foetuses and 41% liveborn children, 
with a balanced sex ratio (1.04). HPE types and facial features were evenly distributed, but 
with a higher frequency of semilobar forms or microforms and of category 2 (38%) or 4 (46%) 
than in the global series (Table 1; Fig 3). Extracraniofacial malformations included four 
multiple congenital abnormalities with no marked association.  
 
Finally, we report seven cases in which a deletion or duplication was associated with a single 
mutation in an HPE-related gene (SHH, ZIC2 and SIX3) (Table 2). The three foetuses and 
four children concerned had either isolated or syndromic HPE, with very various phenotypes 
in terms of HPE type and facial features.  
 
 
 
 
Table 2: Clinical and molecular data for the 8 probands with double mutations: 
rearrangement detected on array-CGH and HPE gene mutation. The inheritance of 
rearrangements and mutations is reported in all cases in which molecular analysis of the 
parents of the proband was possible. The GenBank accession numbers are NM_00193.2 for 
SHH cDNA, NM_007129.2 for ZIC2 cDNA, NM_005413.2 for SIX3 cDNA, NM_003244.2 for 
TGIF cDNA and NM_005270.4 for GLI2 cDNA. 
Rearrangement Proband 
no. 
Foetus (F)   / 
Child (C) Sex Form HPE type 
Facial 
defects 
category 
 Type 
(inheritance) 
Significant 
gene 
Mutation 
(inheritance) 
1 F M syndromic semilobar 2 Dup 3p14.3                  (paternal)   
SHH                
c.388G>T                
(paternal) 
2 F M isolated lobar 2 Del 10p12.1                                                            (paternal) PATCHD3 
SHH                    
c.305G>A            
(paternal)  
3 C M isolated microform 2 Del 10p12.1 PATCHD3 
 SHH                       
c.1040C>G                        
(de novo) 
4 C F isolated microform 3 Del 2q13 NPHP1 
 SHH                   
c.707G>A               
(maternal) 
5 C F isolated semilobar 4 Del 21q21.1                             (de novo)   
ZIC2 
c.1025_1026delAA          
(de novo) 
6 C F isolated semilobar 3 Del 20p12.1 MACROD2 
 SIX3                 
c.760T>G                
(maternal)  
7 F M syndromic alobar 4 Del 13q31.1 q34                             (de novo) ZIC2 
 GLI2                   
c.2717C>G                
(maternal) 
 
 
Statistical analyses 
We carried out statistical analyses to identify significant phenotype-genotype correlations. 
The population of probands with rearrangements was highly heterogeneous. We therefore 
decided to focus on probands with mutations in SHH, ZIC2, SIX3, TGIF, comparing these 
probands with those with no mutation in these genes.  
 
Proportions of foetuses and children 
As expected, the foetuses were significantly more likely to have severe types of HPE, 
whereas the liveborn children tended to have microforms (p<0.0001). However, although 
there were more foetuses with HPE-associated gene deletions or array-CGH 
rearrangements, these differences were not statistically significant (p=0.09 and p=0.2, 
respectively).  
 
HPE types 
Studies of the distribution of HPE types between the five subgroups provided evidence for a 
highly significant correlation (p<0.0001). Alobar HPE tended to be associated with SIX3, 
semilobar HPE with ZIC2 and microform with SHH mutations. Lobar HPE did not seem to be 
particularly associated with any specific HPE gene in these analyses.  
 
Facial defect categories 
Facial features were studied as a function of the severity of the brain malformation. The 
findings for the ZIC2 subgroup differed significantly from those for the other genes, as no 
correlation between the HPE severity type and the severity of facial defects category was 
found (Fig. 3).  
 
We also analysed the facial defects categories independently. A significant difference in the 
distributions of categories 1 and 4 was found, with a low frequency of probands with ZIC2 
mutations in category 1 and a very high frequency of such probands in category 4. A 
significant correlation was also found between SHH microforms and category 3 (p=0.01).  
 
Brain-associated malformations; neural tube defects 
No significant overall correlation was found between associated brain malformations or 
neural tube defects and molecular data, although these defects did appear to be more 
frequent in individuals with ZIC2 and TGIF mutations (p=0.18).  
 
Extracraniofacial defects 
A correlation between renal/urinary malformations and certain mutations (p=0.03) was found. 
Renal/urinary defects were significantly more frequent in probands with SHH and ZIC2 than 
in the probands of other subgroups. No significant difference was found in the distribution of 
the other extracraniofacial defects.  
 
 
DISCUSSION 
 
HPE is a very complex disorder in terms of both clinical variability and genetic signalling 
pathways. We report here the clinical and molecular data for the largest ever European 
series, encompassing 645 probands and 699 relatives, with a higher proportion of foetuses 
(51%) than in previous series.[19, 20, 21] The large number of patients included in this series 
resulted in sufficient power for the detection of statistically significant phenotype-genotype 
correlations.  
 In the series as a whole, the sex ratio (F:M) was 1.2, in favour of a slight predominance of 
female subjects. Female subjects were in the minority among probands with SHH mutations, 
for which the sex ratio was 0.9, whereas a high predominance of female subjects (sex ratio 
of 1.8) was observed among those with ZIC2 and SIX3 mutations. The SIX3 sex ratio was 
consistent with that reported by Lacbawan.[19] This suggests that mutations in ZIC2 or SIX3 
may be embryonic-lethal in males. 
 
Screening for mutations in the major genes SHH, ZIC2, SIX3 and TGIF and the minor gene 
GLI2 in this large series gave an estimated global mutation rate of 25.8%, with specific 
mutation rates of 10.4% (SHH), 8.2% (ZIC2), 5.1% (SIX3), 1.7% (TGIF) and 0.4% (GLI2). 
These results are consistent with our previous findings for smaller series.[1, 9, 18, 34] Point 
mutations in SHH, SIX3 and TGIF were highly heritable, with heritabilities of 73%, 88% and 
100%, respectively, whereas most ZIC2 mutations were de novo (70% of cases).[6, 20] This 
may be due to a higher penetrance and the high frequency of severe HPE in individuals with 
ZIC2 mutations, resulting in the identification of a larger number of sporadic cases. By 
contrast to what was reported by Lacbawan et al., no predominance of maternal inheritance 
was observed for SIX3 mutations in our series, whereas such a pattern of inheritance was 
observed for SHH mutations.[19]  
 
Overall, more severe types of HPE (atelencephaly, alobar or semilobar HPE) were reported 
in individuals with SIX3 (74%) and ZIC2 (75%) mutations than in individuals with SHH (62%) 
and TGIF (57%) mutations. Moreover, atelencephaly/aprosencephaly was associated 
exclusively with SIX3 mutations. Pasquier et al. reported this particular association and other 
teams have reported a high proportion of severe cases in subjects with SIX3 mutations, 
including ophthalmological defects in particular.[19, 20, 33] Thus, alobar HPE tends to be 
associated with SIX3, semilobar HPE with ZIC2 and microforms with SHH, consistent with 
the findings of Solomon.[21] Furthermore, our findings confirmed the specific association of 
MIH or syntelencephaly with ZIC2, as the mutations identified in four of the 11 cases of MIH 
in the series concerned the ZIC2 gene.[6] 
 
This study highlights the considerable intra- and interfamilial phenotypic variability in SHH 
probands.[35] We report here, for the first time, the high prevalence of brain microforms 
(74%) in probands with SHH mutations presenting, essentially, pyriform sinus and choanal 
stenosis (category 3). Associations with midline defects, coloboma and sacral agenesis 
(systematically linked to a large 7q36 deletion) were also observed. By contrast, facial 
morphology in subjects with ZIC2 mutations was generally characterised by moderate facial 
dysmorphia or even a normal face (category 4), associated with alobar or semilobar HPE. 
This feature seems to be specific to ZIC2 mutations and has also been reported by other 
teams.[6, 20] Solomon et al. mentioned a particular facial phenotype found in some of the 
cases in our series, with a high proportion of abnormal noses (9 cases) usually short, 
sometimes flat or large, and ear dysplasia (4 cases). Furthermore, statistical analyses 
revealed a lack of correlation between the severity of HPE brain malformation and facial 
features in probands with ZIC2 mutations, but not in those with SHH, SIX3 and TGIF 
mutations.  
 
We also considered other associated brain malformations, focusing in particular on RES, 
which was associated with HPE in six of the 645 HPE probands. This extremely rare 
malformation is the histological equivalent of HPE for the cerebellum. The signalling 
pathways involved in this disease has yet to be identified, but we suggest that there may be 
interactions with HPE signalling pathways, as a ZIC2 mutation has been reported in two 
siblings with partial RES and HPE.[36, 37] SHH and SIX3 mutations have recently been 
associated with schizencephaly, but only three cases of schizencephaly were reported in our 
series, with no mutation identified in the probands concerned.[31] 
 
We also identified two other previously unknown associations with ZIC2 mutations: 
rachischisis and neuronal migration abnormalities. Neural tube defects are frequently 
reported in HPE, but rachischisis seems to be more specifically associated with ZIC2 
mutation, as such mutations were found in the only two cases of rachischisis in our series. In 
addition, neuronal migration abnormalities have already been described, but without 
phenotype-genotype correlations.[2, 38, 39] We focus here on neuronal migration 
abnormalities, such as gyral pattern abnormalities and heterotopia, which were almost 
exclusively restricted to probands with ZIC2 mutations (8 cases). Hahn et al. found 
subcortical heterotopic grey matter or cortical dysplasia in two thirds of MIH cases.[38] In our 
series, neuronal migration abnormalities were observed in two of 11 cases of MIH, but no 
ZIC2 mutation was identified in these cases.  
 
We report here, for the first time, the frequency and variety of extracraniofacial malformations 
in a large series, together with the corresponding molecular data. Molecular defects were 
more frequent in ZIC2 than in the other three main genes. We found a higher frequency of 
extracraniofacial defects than reported by Solomon, probably because his study focused on 
children, rather than foetuses.[6] Renal/urinary defects were significantly associated with 
SHH or ZIC2 mutations and no such defects were found in probands with SIX3 or TGIF 
mutations. SIX3 was the only gene for which no heart defect was reported.  
 
The data for TGIF and, above all, for GLI2 revealed no significant phenotype-genotype 
correlations, but alobar HPE with severe facial features (category 1) seemed to be more 
frequent in probands with TGIF mutations, although phenotypic variability was high. We 
suggest that phenotype-genotype correlations for TGIF and GLI2 should be analysed in 
larger series. Another disease spectrum, characterised by anterior pituitary insufficiency and 
polydactyly, seems to be more specifically linked to GLI2 mutations[23, 40] (Dubourg, 
unpublished data).  
 
Several signalling pathways are known to be involved in HPE, and the various mechanisms 
underlying HPE may account for the observed phenotypic variability. Indeed, SIX3 is 
involved in eye development, consistent with the eye defects observed in probands with SIX3 
mutations, and in ventral forebrain development, through regulation of the SHH signalling 
pathway. Furthermore, ZIC2 significantly differs from the other HPE-related genes, as shown 
in phenotype-genotype correlations, and its product also acts by different mechanisms. 
Indeed, ZIC2 is known to act both early stage, in upstream SHH signalling during mid-
gastrulation, and at later stages, in the development of the dorsal telencephalon, potentially 
accounting for the specific occurrence of MIH and neural tube defects in ZIC2 probands.  
 
Array-CGH studies in this series confirmed the high frequency of rearrangements reported in 
a preliminary study.[26] Indeed, rearrangements were identified in 22% of the 260 patients 
studied (14% de novo and 8% inherited). The proportion of foetuses and the severity of HPE 
phenotype (extracraniofacial malformations included) were not significantly higher in 
probands with rearrangements than in the series as a whole, as might have been expected. 
The higher frequency of category 2 and 4  probands may reflect more common features, 
such as cleft lip or palate (category 2) or mild non-specific features (category 4). This 
population seemed to be heterogeneous and an understanding of the molecular basis of this 
heterogeneity should facilitate the definition of more homogeneous subgroups. Indeed, the 
high frequency of rearrangements was consistent with there being a large number of loci 
corresponding to new candidate genes. The recurrent regions included the MACROD2 and 
PATCHD3 loci, in particular. Furthermore, recurrent deletion 6qter led to the identification of 
DLL1 as a new HPE-associated gene and of NOTCH as a new signalling pathway involved 
in HPE.[41] 
 
It has already been suggested that HPE involves a multiple-hit process.[26, 42] Animal 
models have provided evidence of digenism, by implicating either the same or two different 
signalling pathways. Genetic background also played an important role in determining the 
severity of the phenotype.[43, 44, 45] In humans, low penetrance or variable levels of 
expression in HPE multiplex families and reports of patients with two different mutations 
support this hypothesis.[16, 24, 46, 47] Our series included up to 15 cases of double 
mutation: eight cases of double rearrangements and seven cases of rearrangement 
associated with a mutation in an HPE-related gene (6 rearrangements associated with a 
mutation in SHH, ZIC2 or SIX3 and one ZIC2 deletion associated with a GLI2 mutation). This 
findings provide solid support for the multiple-hit hypothesis in HPE.  
 
In conclusion, even if the identification of an HPE gene mutation cannot provide a precise 
prognosis, the new phenotype-genotype correlations identified here should facilitate the 
definition of a better molecular analysis strategy. We propose a new algorithm based on 
these correlations (Fig. 3). Evidence of double mutations in HPE probands provides support 
for the HPE multiple-hit hypothesis underlying the complexity of genetic counselling and 
research on this disorder. The known clinical variability of HPE also suggests an overlap 
between environmental and genetic mechanisms. A combination of clinical and functional 
studies should help to improve our understanding of the complex interactions between the 
various signalling pathways involved in HPE and brain development.  
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Legends: 
 
 
Figure 1: Schematic representation of point mutations and deletions in the SHH, ZIC2, SIX3, TGIF genes. 
Point mutations are represented in yellow and gene deletions are shown in red, with the corresponding number of 
probands. The percentage of probands (/645 probands) with a particular point mutation or a deletion is noted 
below each gene. 
 
Figure 2: Point mutations and inheritance of the SHH, ZIC2, SIX3 and TGIF genes. SHH: 41 different 
variations (73% missense, 27% nonsense or frameshift mutations); 73% inherited point mutations, predominantly 
of maternal (67%) rather than paternal (33%) origin. ZIC2: 44 different point mutations (29% missense, 55% 
nonsense or frameshift, 13% polyalanine tract, 3% splice alterations) with 70% occurring “de novo” and two cases 
of probable germline mosaicism. SIX3: 18 different point mutations (78% missense, 22% nonsense or frameshift). 
TGIF: 3 missense mutations and 1 nonsense mutation. The pathogenicity of these alterations has been confirmed 
by predictive or functional studies.[6, 18, 28, 29, 30] GenBank accession numbers are NM_00193.2 for SHH 
cDNA, NM_007129.2 for ZIC2 cDNA, NM_005413.2 for SIX3 cDNA and NM_003244.2 for TGIF cDNA.   
 
 
 
Figure 3: Face defect category, as a function of HPE type, for the series as a whole, probands with 
abnormal array-CGH findings and with altered SHH, ZIC2, SIX3 and TGIF genes. The results presented are 
based on the data for 369 informative probands. Considering a positive gradient of severity from category 1 to 
category 4 in Spearman’s rank correlation test, we found a significant correlation between the severity of HPE 
type and facial features for the entire series (p<0.001) and for the SHH (p<0.001), SIX3 (p<0.001) and TGIF 
(p<0.001) subgroups, but not for the ZIC2 subgroup (p=0.5).  
 
 
 
 
Figure 4: Algorithm for molecular analysis in HPE. In cases of familial HPE, analyses of SHH, SIX3 or TGIF 
should be given priority over ZIC2 analysis. Very severe forms of HPE, such as alobar and semilobar HPE, 
should lead to analyses of the SIX3 (particularly in cases of atelencephaly/aprosencephaly) and ZIC2 genes, but 
facial features may provide useful information. Indeed, probands with category 1 or 2 facial features associated 
with severe HPE, such as alobar or semilobar HPE, are more likely to display mutations in SIX3 or SHH. By 
contrast, probands with severe brain malformations and category 4 facial features are likely to have mutations in 
ZIC2. No particular association with lobar HPE was found. Thus, if associated brain malformations are described, 
particularly in cases of neuronal migration abnormalities, and in cases of neuronal tube defects (rachischisis in 
particular), ZIC2 gene analysis should be performed as a matter of priority.  Moreover, ZIC2 mutations are the 
principal cause of extracraniofacial malformations. Renal/urinary malformations are found preferentially in patients 
with ZIC2 or SHH mutations and coloboma tends to be found in patients with SHH or SIX3 mutations. 
 
